Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026

Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026 Demis Hassabis's DeepMind spinout just closed a $2.1 billion Series B led by Thrive Capital with new participation from Temasek, CapitalG, the UK Sovereign AI Fund, and Abu Dhabi's MGX. Rick and Laura unpack what the IsoDDE engine, the Novartis, Eli Lilly, and Johnson & Johnson partnerships, and a Phase one trial target by year end mean for...